Huang et al. found that telmisartan, which is one of the ARB family and also partly functions as PPAR-γ agonist, improved insulin resistance by activating AMPK and diminishing ER stress and alleviated hepatic steatosis in mice fed a HFD [171]. The gene discussed is PPARG; the disease is Insulin resistance.